A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

July 3, 2023

Study Completion Date

July 3, 2023

Conditions
Dendritic Cell -Mediated Rheumatic Diseases
Interventions
DRUG

VIB1116

VIB1116

DRUG

Placebo

Placebo

Trial Locations (11)

36207

Pinnacle Research Group, Anniston

70605

Accurate Clinical Research, Lake Charles

75231

Rheumatology Associates, Dallas

33765-2616

Clinical Research of W FL, Clearwater

32216-4362

Jacksonville Clinical Research, Jacksonville

16635-8445

Altoona Clinical Research, Duncansville

75150-6919

SW Rheumatology Center, Mesquite

78229-3539

Clinical Trials of Texas, Inc., San Antonio

61-545

Klinika Reumatologii i Rehabilitacji Ortopedyczno-Rehabilitacyjny Szpital Kliniczny im W. Degi, Poznan

85-168

Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy, Bydgoszcz

02-691

ARS RHEUMATICA Sp. z o.o. REUMATIKA-Centrum Reumatologii NZOZ, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY